Deep Track Capital LP 13D and 13G filings for Esperion Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-14 08:42 am Sale | 2023-12-31 | 13G | Esperion Therapeutics, Inc. ESPR | Deep Track Capital LP | 0 0.000% | -6,345,790 (Position Closed) | Filing |
| 2021-12-09 4:54 pm Purchase | 2021-12-03 | 13G | Esperion Therapeutics, Inc. ESPR | Deep Track Capital LP | 6,345,790 9.990% | 6,345,790 (New Position) | Filing |